KRAS G12V

Clinical trials for KRAS G12V explained in plain language.

Never miss a new study

Get alerted when new KRAS G12V trials appear

Sign up with your email to follow new studies for KRAS G12V, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

Supercharged T-Cells take on Hard-to-Treat cancers

Disease control Not yet recruiting

This early-phase trial tests a new therapy called TCR-T cells, which are immune cells engineered to recognize and attack cancer cells with specific KRAS mutations (G12V or G12D). The study will enroll 25 adults with advanced solid tumors (like colorectal or lung cancer) who have …

Matched conditions: KRAS G12V

Phase: EARLY_PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

KRAS G12V

Get alerted when new KRAS G12V trials appear

Supercharged T-Cells take on Hard-to-Treat cancers